garded as a disease whose initial manifestations almost always occur in individuals younger than 40 years of age. Young children typically present with liver disease, whereas in teenagers and young adults, neurological manifestations predominate (2). However, there are a few very rare case reports of Wilson's disease with apparent onset in late adulthood (3-7).
We report a male patient with Fanconi's syndrome who was first diagnosed with Wilson's disease at age 65 years after he presented for diagnostic assessment of chronic liver disease. The clinical diagnosis was based on the presence of bilateral Kayser-Fleischer rings, a decreased serum ceruloplasmin level, markedly elevated urine copper excretion and a liver biopsy staining histochemically positive for copper.
CASE PRESENTATION
A 65-year-old man with renal failure and Fanconi's syndrome was seen in January 1992 for investigation of chronic liver disease. In 1967, he developed a seizure disorder after sustaining a head injury with loss of consciousness; he was subsequently treated with phenytoin 200 mg daily. Fanconi's syndrome was diagnosed in 1984 (at age 57) with a pattern of generalized amino-aciduria, hyperphosphaturia and osteomalacia. Liver disease was first identified at age 61 years when the patient presented with ascites. A liver biopsy was performed. This yielded a fragmented specimen that was reported to reveal fibrosis and 'pigmentation' but no specific diagnosis was established.
Because of his chronic liver disease and worsening ascites, the patient was referred for further evaluation. weight gain of 14 kg, anorexia and inability to concentrate. There was no history of risk factors for parenterally transmitted viral hepatitis or alcohol abuse. There was no family history of known liver disease or neuropsychiatric disorder.
His original liver biopsies were reviewed and the paraffin-embedded liver tissue blocks were reprocessed for histochemical stains; sections tested positive with orcein and rubeanic acid stains for copper.
Physical examination revealed a healthy appearing man with no clinical evidence of jaundice. Bilateral Kayser-Fleischer rings were visible to the naked eye and later confirmed on slit lamp biomicroscopy (Figure 1 ). Other less frequently reported ocular changes, ie, sunflower cataracts or an intraocular foreign body containing copper (chalcosis), were not seen. Neurological examination was normal except for slight right facial drooping. His abdomen was markedly distended with ascites. Peripheral stigmata of chronic liver disease were evident including spider nevi, gynecomastia, palmer erythema, multiple bruises and Dupuytren's contractures. Edema was present bilaterally to the midabdomen.
Laboratory investigations revealed (normal range in parentheses): hemoglobin 123 g/L (140 to 180); white blood cell count 3.1x10 9 /L (4 to 11x10 9 ); platelets 90x10 9 /L (140 to 350x10 9 ); serum creatinine 198 mmol/L (80 to 120); blood urea nitrogen 7.5 mM (2.5 to 6.8); alkaline phosphatase 95 U/L (30 to 110); aspartate aminotransferase 28 U/L (5 to 47); total bilirubin 17 mmol/L (2 to 23); international normalized ratio 1.5 (0.9 to 1.2); and serum albumin 36 g/L (35 to 50). Serum copper was 16.0 mmol/L (normal 11.0 to 22.0) and serum ceruloplasmin was 75 mg/L (normal 150 to 600). Antinuclear and antimitochondrial antibodies were negative. Iron studies and alpha-1-antitrypsin were normal. Serological studies for hepatitis A, B and C were negative. Urine copper was 4.8 mmol/24 h (normal 0.5 to 0.9). An abdominal ultrasound showed massive ascites and a small, nodular liver. Bile ducts were not dilated and no gallstones were seen. A paracentesis revealed a transudate with negative cytology. Upper endoscopy revealed esophageal, but no gastric, varices. Computed tomography and magnetic resonance imaging of the brain showed generalized atrophy but no changes in the basal ganglia.
The patient was treated with penicillamine 500 mg bid, and this increased his urinary copper excretion to 18.1 mmol/24 h.
DISCUSSION
Different mechanisms have been implicated in the pathogenesis of Wilson's disease. The liver acts as a depot for copper. As the disease progresses, due to an inherited defect not yet completely understood, copper binding sites in the liver become saturated. This factor, along with direct hepatocellular damage, results in release of copper into the blood, which then proceeds to deposit in the cornea and basal ganglia (7). The reversal of abnormal copper metabolism in patients after orthotopic liver transplantation supports the critical role played in the pathogenesis of Wilson's disease by the liver.
Recent studies have provided data on the identification of the gene responsible for Wilson's disease, which has been identified on chromosome 13. The gene product appears to be a copper-binding P-type ATPase protein and is apparently homologous to the Menkes disease gene (8). Mutation analysis has so far uncovered a number of disease-specific mutations, including transversions and frame shift mutations, affecting the Wilson's disease protein (8).
Many texts of general internal medicine assert that Wilson's disease is generally a disorder of patients younger than 40 years of age. It is believed that the hepatic form generally occurs in children while the neurological form is generally, but not exclusively, seen in older patients.
It has been stated that KayserFleischer rings and the neurological manifestations of the disease are invariably present together (2). The present case illustrates that these dicta are not necessarily true even though modern methods of imaging detection for central nervous system involvement in Wilson's disease were used in our patient, including computed tomography and magnetic resonance.
Despite his age of 65, there is little question that this patient -with chronic liver disease and Fanconi's syndrome -had Wilson's disease. His diagnosis was based on a high urine copper excretion measurement, the presence of bilateral Kayser-Fleischer rings, a reduced serum ceruloplasmin level and 
